NDC 86136-011 - Betacilin Clav Drops
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86136-011
- Package NDCs from labels
- 86136-011-15
- Manufacturer
- MWI Animal Health
- Effective date
- 2024-08-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Betacilin Clav Drops - MWI Animal Health | MWI Animal Health | 2024-08-29 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86136-011-15 | Betacilin Clav Drops | 15 mL in 1 BOTTLE | SUSPENSION | 15 | 2 | |
| 86136-011-15 | Betacilin Clav Drops | 1 in 1 CARTON | SUSPENSION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals, Inc. | 348f7f77-ba7e-5dd9-e063-6294a90a0991 | 2025-05-07 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sandoz Inc | e41387c8-2c74-4990-831f-64dc921ee138 | 2025-05-01 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sandoz Inc | 7cba82f0-9886-46e9-8dbd-43a448aade29 | 2025-05-01 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NorthStar Rx LLC | df4136c0-9efd-42c3-a487-e728e8b91275 | 2025-04-03 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals, Inc. | 31d00820-1c20-d52b-e063-6394a90ac312 | 2025-04-02 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | b0d7eb3e-706a-482b-b106-9c137be55bb6 | 2025-04-01 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Devatis Inc. | a884cff6-bffd-41fd-904c-c694c995f338 | 2025-03-11 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals, Inc. | 30144e2e-d336-8fa3-e063-6394a90a6068 | 2025-03-11 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Devatis, Inc. | 90d0aa94-5c32-4fb7-8561-8763810d2847 | 2025-03-11 | Warnings, Adverse reactions | Q42OMW3AT8 |
| amoxicillin and clavulanate potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Devatis, Inc. | b0b2e164-e70d-471f-92ce-abdac6cb405f | 2025-03-10 | Warnings, Adverse reactions | 617322 Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | c8030539-314f-437d-abe7-415d6e58add7 | 2025-03-01 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Hikma Pharmaceuticals USA Inc. | 6339bcdb-060f-4558-9f42-6bf7f935e138 | 2025-02-28 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | a0822381-ba9a-4f80-bc4f-608301d07fd8 | 2025-02-27 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | f9b4d263-bc5b-6065-e053-6394a90a5e35 | 2025-02-10 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Advanced Rx Pharmacy of Tennessee, LLC | f601c634-2271-2fcd-e053-2995a90aaaba | 2025-02-02 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Advanced Rx Pharmacy of Tennessee, LLC | d294e4a2-8ce7-418d-e053-2a95a90ab10b | 2025-02-02 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin/Clav Pot Oral Susp | AMOXICILLIN/CLAV POT ORAL SUSP | Direct_Rx | e5bd9918-b073-c50b-e053-2a95a90aaeb7 | 2025-01-22 | Warnings, Adverse reactions | Q42OMW3AT8 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | DirectRx | cdc6d30a-754e-6672-e053-2a95a90afa7f | 2025-01-20 | Warnings, Adverse reactions | Q42OMW3AT8 |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals, Inc. | 2bb03d3b-5d44-bc4a-e063-6394a90a656a | 2025-01-14 | Warnings, Adverse reactions | Q42OMW3AT8 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sandoz Inc | 99b7f40a-06f9-4b97-8eee-8e61e5106aad | 2025-01-08 | Warnings, Adverse reactions | Q42OMW3AT8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.